Literature DB >> 12637728

Cancer. Developing molecular biomarkers for cancer.

David F Ransohoff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12637728     DOI： 10.1126/science.1083158

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  20 in total

Review 1.  Blood biologic markers of stroke: improved management, reduced cost?

Authors:  Alison E Baird
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

Review 2.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

3.  Omics-based molecular target and biomarker identification.

Authors:  Zhang-Zhi Hu; Hongzhan Huang; Cathy H Wu; Mira Jung; Anatoly Dritschilo; Anna T Riegel; Anton Wellstein
Journal:  Methods Mol Biol       Date:  2011

Review 4.  The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

Authors:  Tracy J Doyle; Victor Pinto-Plata; Danielle Morse; Bartolome R Celli; Ivan O Rosas
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

Review 5.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

Review 6.  Epigenetics in bladder cancer.

Authors:  Hideki Enokida; Masayuki Nakagawa
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

Review 7.  Blood-based testing for colorectal cancer screening.

Authors:  Karen A Heichman
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

8.  Sources of bias in specimens for research about molecular markers for cancer.

Authors:  David F Ransohoff; Margaret L Gourlay
Journal:  J Clin Oncol       Date:  2009-12-28       Impact factor: 44.544

9.  Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients.

Authors:  Zohar A Dotan; Aviva Dotan; Jacob Ramon; Lydia Avivi
Journal:  BMC Cancer       Date:  2008-12-25       Impact factor: 4.430

10.  Biomarkers for early detection of high risk cancers: from gliomas to nasopharyngeal carcinoma.

Authors:  Oluwadayo Oluwadara; Francesco Chiappelli
Journal:  Bioinformation       Date:  2009-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.